NORETHINDRONE Drug Patent Profile
✉ Email this page to a colleague
When do Norethindrone patents expire, and when can generic versions of Norethindrone launch?
Norethindrone is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Lupin Ltd, Naari Pte Ltd, Novast Labs, Xiromed, Aurobindo Pharma Ltd, Barr, Barr Labs Inc, Dr Reddys Labs Sa, Apotex, Watson Labs, Watson Pharms Teva, Mylan Labs Ltd, Watson Labs Teva, and Teva Branded Pharm. and is included in sixty-three NDAs.
The generic ingredient in NORETHINDRONE is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE?
- What are the global sales for NORETHINDRONE?
- What is Average Wholesale Price for NORETHINDRONE?
Summary for NORETHINDRONE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 63 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 85 |
| Patent Applications: | 3,792 |
| Drug Prices: | Drug price information for NORETHINDRONE |
| Drug Sales Revenues: | Drug sales revenues for NORETHINDRONE |
| DailyMed Link: | NORETHINDRONE at DailyMed |
See drug prices for NORETHINDRONE
Recent Clinical Trials for NORETHINDRONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bio Genuine (Shanghai) Biotech Co., Ltd. | Phase 3 |
| Myovant Sciences GmbH | Phase 4 |
| University of Chicago | Phase 4 |
Pharmacology for NORETHINDRONE
| Drug Class | Progestin |
